Biogen Initiates Global Phase 3 BRAVE Study to Evaluate Omaveloxolone for Pediatric Friedreich Ataxia
18/6 13:42
Biogen launches Phase 3 BRAVE study to assess omaveloxolone's effects in children with Friedreich ataxia....
|
|
|
18/6 13:42
Biogen launches Phase 3 BRAVE study to assess omaveloxolone's effects in children with Friedreich ataxia....